245 related articles for article (PubMed ID: 18050304)
1. A new type of MAML2 fusion in mucoepidermoid carcinoma.
Fehr A; Röser K; Heidorn K; Hallas C; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2008 Mar; 47(3):203-6. PubMed ID: 18050304
[TBL] [Abstract][Full Text] [Related]
2. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
Fehr A; Meyer A; Heidorn K; Röser K; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2009 Sep; 48(9):777-85. PubMed ID: 19521953
[TBL] [Abstract][Full Text] [Related]
3. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.
Nakayama T; Miyabe S; Okabe M; Sakuma H; Ijichi K; Hasegawa Y; Nagatsuka H; Shimozato K; Inagaki H
Mod Pathol; 2009 Dec; 22(12):1575-81. PubMed ID: 19749740
[TBL] [Abstract][Full Text] [Related]
5. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
[TBL] [Abstract][Full Text] [Related]
6. CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association.
Bell D; Luna MA; Weber RS; Kaye FJ; El-Naggar AK
Genes Chromosomes Cancer; 2008 Apr; 47(4):309-14. PubMed ID: 18181164
[TBL] [Abstract][Full Text] [Related]
7. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
Achcar Rde O; Nikiforova MN; Dacic S; Nicholson AG; Yousem SA
Hum Pathol; 2009 Jun; 40(6):854-60. PubMed ID: 19269006
[TBL] [Abstract][Full Text] [Related]
8. Thymic Mucoepidermoid Carcinoma: Report of a Case With CTRC1/3-MALM2 Molecular Studies.
Prieto-Granada CN; Inagaki H; Mueller J
Int J Surg Pathol; 2015 Jun; 23(4):277-83. PubMed ID: 25782731
[TBL] [Abstract][Full Text] [Related]
9. Oncocytic mucoepidermoid carcinoma of the parotid gland with CRTC1-MAML2 fusion transcript: report of a case with review of literature.
Fujimaki M; Fukumura Y; Saito T; Mitani K; Uchida S; Yokoyama J; Yao T; Ikeda K
Hum Pathol; 2011 Dec; 42(12):2052-5. PubMed ID: 21676434
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma.
Noda H; Okumura Y; Nakayama T; Miyabe S; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Cancer Sci; 2013 Jan; 104(1):85-92. PubMed ID: 23035786
[TBL] [Abstract][Full Text] [Related]
11. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.
Tirado Y; Williams MD; Hanna EY; Kaye FJ; Batsakis JG; El-Naggar AK
Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281
[TBL] [Abstract][Full Text] [Related]
12. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.
Okabe M; Miyabe S; Nagatsuka H; Terada A; Hanai N; Yokoi M; Shimozato K; Eimoto T; Nakamura S; Nagai N; Hasegawa Y; Inagaki H
Clin Cancer Res; 2006 Jul; 12(13):3902-7. PubMed ID: 16818685
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.
Chen J; Li JL; Chen Z; Griffin JD; Wu L
BMC Cancer; 2015 Oct; 15():803. PubMed ID: 26503699
[TBL] [Abstract][Full Text] [Related]
14. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene.
Behboudi A; Enlund F; Winnes M; Andrén Y; Nordkvist A; Leivo I; Flaberg E; Szekely L; Mäkitie A; Grenman R; Mark J; Stenman G
Genes Chromosomes Cancer; 2006 May; 45(5):470-81. PubMed ID: 16444749
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
[TBL] [Abstract][Full Text] [Related]
18. CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland.
Von Holstein SL; Fehr A; Heegaard S; Therkildsen MH; Stenman G
Oncol Rep; 2012 May; 27(5):1413-6. PubMed ID: 22323114
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous hidradenoma: a study of 21 neoplasms revealing neither correlation between the cellular composition and CRTC1-MAML2 fusions nor presence of CRTC3-MAML2 fusions.
Kyrpychova L; Kacerovska D; Vanecek T; Grossmann P; Michal M; Kerl K; Kazakov DV
Ann Diagn Pathol; 2016 Aug; 23():8-13. PubMed ID: 27402217
[TBL] [Abstract][Full Text] [Related]
20. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.
Coxon A; Rozenblum E; Park YS; Joshi N; Tsurutani J; Dennis PA; Kirsch IR; Kaye FJ
Cancer Res; 2005 Aug; 65(16):7137-44. PubMed ID: 16103063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
